Clinical Research
Total Trials
4
As Lead Sponsor
0
As Collaborator
Total Enrollment
314
NCT03660787
Efficacy and Dose Ranging Study of Seroguard
Phase: Phase 2
Role: Collaborator
Start: May 4, 2017
Completion: Jan 23, 2018
NCT03291002
Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC
Phase: Phase 1
Start: Sep 25, 2017
Completion: Feb 28, 2023
NCT04452474
Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).
Phase: Phase 2/3
Start: Jun 30, 2020
Completion: Jan 29, 2021
NCT04463251
Study to Evaluate the Effect on Parameters of Systemic Inflammation and Disease Outcomes and Safety of RPH-104 in Subjects With Acute ST-elevation Myocardial Infarction
Start: Dec 7, 2020
Completion: Oct 10, 2022
Loading map...